Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on PK of Tianeptine (JNJ-39823277) in Healthy Subjects
NCT02103985Phase 1Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tianeptine in major depressive disorder (MDD) (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Maximum Observed Plasma Concentration at 36 hours, Time to Reach Maximum Observed Plasma Concentration at 36 hours and 8 more. Started May 2009; status: completed.
02
Drugs
tianeptine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02103985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103985.